In conclusion, we have demonstrated for the first time that IL-27 can regulate tumor cell growth by favoring proliferation of human AML and erythroleukemic cells, suggesting that IL-27 may represent a promising potential therapeutic target for certain subtypes of leukemia. Here, IL27 is linked to acute myeloid leukemia.